Local overexpression of GH and GH/IGF1 effects in the adult mouse hippocampus

被引:7
|
作者
Walser, Marion [1 ]
Sama, Maria Teresa [1 ,2 ]
Wickelgren, Ruth [3 ]
Aberg, Maria [4 ,5 ]
Bohlooly-Y, Mohammad [6 ]
Olsson, Bob [7 ]
Tornell, Jan [8 ]
Isgaard, Jorgen [1 ]
Aberg, N. David [1 ,5 ]
机构
[1] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Internal Med, Lab Expt Endocrinol, SE-41345 Gothenburg, Sweden
[2] Univ Piemonte Orientale, Dept Clin & Expt Med, Novara, Italy
[3] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden
[4] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, Dept Primary Hlth Care, SE-41345 Gothenburg, Sweden
[5] Univ Gothenburg, Sahlgrenska Univ Hosp, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, SE-41345 Gothenburg, Sweden
[6] AstraZeneca Res & Dev, SE-43183 Molndal, Sweden
[7] Inst Neurosci & Physiol, Dept Neurochem & Psychiat, Clin Neurochem Lab, SE-43180 Molndal, Sweden
[8] InnoExt AB, SE-42167 Vastra Frolunda, Sweden
关键词
GROWTH-HORMONE GH; CENTRAL-NERVOUS-SYSTEM; FACTOR-I RECEPTOR; QUALITY-OF-LIFE; HYPOPHYSECTOMIZED RATS; TRANSGENIC MICE; POSTSYNAPTIC DENSITY; PERIPHERAL INFUSION; CELL-PROLIFERATION; LOCOMOTOR-ACTIVITY;
D O I
10.1530/JOE-12-0077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GH therapy improves hippocampal functions mainly via circulating IGF1. However, the roles of local GH and IGF1 expression are not well understood. We investigated whether transgenic (TG) overexpression in the adult brain of bovine GH (bGH) under the control of the glial fibrillary acidic protein (GFAP) promoter affected cellular proliferation and the expression of transcripts known to be induced by systemic GH in the hippocampus. Cellular proliferation was examined by 5-bromo-2'-deoxyuridine immunohistochemistry. Quantitative PCR and western blots were performed. Although robustly expressed, bGH-Tg did not increase either cell proliferation or survival. However, bGH-Tg modestly increased Igf1 and Gfap mRNAs, whereas other GH-associated transcripts were unaffected, i.e. the GH receptor (Ghr), IGF1 receptor (Igf1r), 2',3'-cyclic nucleotide 3'-phosphodiesterase (Cnp), ionotropic glutamate receptor 2a (Nr2a (Grin2a)), opioid receptor delta (Dor), synapse-associated protein 90/postsynaptic density-95-associated protein (Sapap2 (Dlgap2)), haemoglobin beta (Hbb) and glutamine synthetase (Gs (Glul)). However, IGF1R was correlated with the expression of Dor, Nr2a, Sapap2, Gs and Gfap. In summary, although local bGH expression was robust, it activated local IGF1 very modestly, which is probably the reason for the low response of previous GH-associated response parameters. This would, in turn, indicate that hippocampal GH is less important than endocrine GH. However, as most transcripts were correlated with the expression of IGF1R, there is still a possibility for endogenous circulating or local GH to act via IGF1R signalling. Possible reasons for the relative bio-inactivity of bGH include the bell-shaped dose-response curve and cell-specific expression of bGH. Journal of Endocrinology (2012) 215, 257-268
引用
下载
收藏
页码:257 / 268
页数:12
相关论文
共 50 条
  • [1] Neurotrophic and Neuroregenerative Effects of GH/IGF1
    Bianchi, Vittorio Emanuele
    Locatelli, Vittorio
    Rizzi, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11):
  • [2] GH & IGF1: Aspects of Global and Local Release and Actions
    Robinson, Iain C. A. F.
    IGFS: LOCAL REPAIR AND SURVIVAL FACTORS THROUGHOUT LIFE SPAN, 2010, : 1 - 10
  • [3] Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak
    Feldt-Rasmussen, Ulla
    Brabant, Georg
    Maiter, Dominique
    Jonsson, Bjorn
    Toogood, Andy
    Koltowska-Haggstrom, Maria
    Rasmussen, Aase Krogh
    Buchfelder, Michael
    Saller, Bernhard
    Biller, Beverly M. K.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 168 (05) : 733 - 743
  • [4] GH, IGF1 and mammary epithelial hyperplasia
    Zhou, J
    Ng, ST
    Adesanya, OO
    Bondy, CA
    22ND CONGRESS OF THE INTERNATIONAL ASSOCIATION FOR BREAST CANCER RESEARCH, 1999, : 25 - 29
  • [5] GH and IGF1 in cancer therapy resistance
    Basu, Reetobrata
    Kopchick, John J.
    ENDOCRINE-RELATED CANCER, 2023, 30 (09)
  • [6] GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?
    G. Cuatrecasas
    C. Alegre
    F. F. Casanueva
    Pituitary, 2014, 17 : 277 - 283
  • [7] Upregulation of GH, but not IGF1, in the hippocampus of the lactating dam after kainic acid injury
    Arellanes-Licea, Elvira C.
    Avila-Mendoza, Jose
    Ramirez-Martinez, Elizabeth C.
    Ramos, Eugenia
    Uribe-Gonzalez, Nancy
    Aramburo, Carlos
    Morales, Teresa
    Luna, Maricela
    ENDOCRINE CONNECTIONS, 2018, 7 (02): : 258 - 267
  • [8] GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?
    Cuatrecasas, G.
    Alegre, C.
    Casanueva, F. F.
    PITUITARY, 2014, 17 (03) : 277 - 283
  • [9] A journey up and down the GH/IGF1 axis
    Robinson, Iain C. A. F.
    HORMONE RESEARCH, 2009, 72 : 13 - 13
  • [10] Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice
    Sun, LY
    Al-Regaiey, K
    Masternak, MM
    Wang, H
    Bartke, A
    NEUROBIOLOGY OF AGING, 2005, 26 (06) : 929 - 937